Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

9.1%

153 terminated/withdrawn out of 1676 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

111 trials in Phase 3/4

Results Transparency

40%

498 of 1230 completed trials have results

Key Signals

163 recruiting498 with results96 terminated57 withdrawn

Enrollment Performance

Analytics

N/A

976(72.0%)

Phase 2

128(9.4%)

Phase 1

123(9.1%)

Phase 4

79(5.8%)

Phase 3

32(2.4%)

Early Phase 1

18(1.3%)

1356Total

N/A(976)

Phase 2(128)

Phase 1(123)

Phase 4(79)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1676)

Showing 20 of 1676 trials

NCT05464888Not ApplicableRecruiting

Animal Assisted Therapy in Pediatric Dentistry

Role: lead

NCT04117360Recruiting

Orthognathic Speech Pathology: Phonetic Contrasts of Patients With Dental Discrepancies Pre- and Post-Treatment Analyses

Role: lead

NCT05904145Recruiting

PRISMA Maternal and Newborn Health Study

Role: collaborator

NCT07488221Not ApplicableCompleted

Male Partner Engagement in HIV Testing Using Partner-notification Slip Plus Oral HIV Self-testing Kit

Role: lead

NCT04469959Phase 2Completed

Dopaminergic Dysfunction in Late-Life Depression

Role: collaborator

NCT00916682Completed

Structure and Function of Salivary Proteins

Role: collaborator

NCT05796141Not ApplicableActive Not Recruiting

Becoming United in Lifestyle Decisions

Role: collaborator

NCT03696797Not ApplicableCompleted

Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease

Role: collaborator

NCT06744231Not ApplicableEnrolling By Invitation

Thriving Hearts: Healing-Centered, Integrated, Community Maternity Care

Role: lead

NCT03554356Not ApplicableActive Not Recruiting

Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)

Role: lead

NCT05746273Phase 2Active Not Recruiting

Depressed Mood Improvement Through Nicotine Dosing 3

Role: collaborator

NCT05746546Phase 2Active Not Recruiting

Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension

Role: collaborator

NCT07581938Recruiting

Early Dental Risk Screening for Pediatric Sleep-Disordered Breathing

Role: lead

NCT05701657Not ApplicableRecruiting

Nutrition for Precision Health, Powered by the All of Us

Role: collaborator

NCT05033990Recruiting

SPIROMICS Study of Early COPD Progression (SOURCE)

Role: collaborator

NCT07101640Phase 1Recruiting

PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia

Role: collaborator

NCT02984124Phase 2Completed

Communication During Hospitalization About Resuscitation Trial

Role: collaborator

NCT07463209Not ApplicableNot Yet Recruiting

Integrating New Skills Into Diabetes Education With CGM

Role: lead

NCT06687746Completed

Evaluation of Bili-ruler, a Low-cost, Plastic Icterometer for Community-based Screening of Jaundice in Newborns

Role: collaborator

NCT05848622Not ApplicableRecruiting

Gait Rehabilitation to Treat FastOA

Role: lead